Nanomedicine News

RSS

Quest PharmaTech’s Nanoformulation of Photosensitizer Demonstrates Superior Anti-tumor Effect

Quest PharmaTech, a biotechnology firm specializing in cancer treatment products, has declared that the Journal of Photochemistry and Photobiology has accepted to publish a research paper titled ‘Antitumor Efficacy of Photodynamic Therapy Using Novel Nanoformulations of Hypocrellin Photosensitizer SL052.’

2 Dec 2011

Bacteria Destroying Nanoparticle Developed by IBN and IBM Named as a Top 10 World Changing Idea

A nanoparticle that can destroy drug-resistant bacteria developed by the Institute of Bioengineering and Nanotechnology (IBN), and the IBM Almaden Research Center, has recently been named one of 10 world changing ideas by Scientific American in its Technology Special Report (‘World Changing Ideas – 10 New Technologies That Will Make a Difference’, December 2011).

From Institute of Bioengineering and Bioimaging 30 Nov 2011

Drug Delivery Companies Partner to Develop Commercial Production Process for Silicon Nanoparticles

Drug delivery companies, NanoMedical Systems and Leonardo Biosystems have inked a development deal wherein NanoMedical Systems will design and launch a commercial production process for nanoporous silicon particles used in the multi-stage drug delivery system of Leonardo Biosystems.

30 Nov 2011

Lipid Nanoparticle Technology Developer Secures FDA Approval to Start TKM-Ebola Clinical Trial

Tekmira Pharmaceuticals has declared that the United States Food and Drug Administration (FDA) approved its TKM-Ebola investigational new drug (IND) application, paving the way for the company to start a Phase 1 clinical study.

30 Nov 2011

Malvern's Light Scattering to Make Impact in Biopharmaceutical Development

Scientists from Malvern Panalytical and from biological ingredients and technology developers, Novozymes Biopharma, have successfully completed the first phase of extensive collaborative studies.

From Malvern Panalytical 29 Nov 2011

SUSS Microtech Collaborate with Swansea University's Centre for NanoHealth

SUSS MicroTec, a leading supplier of equipment and process solutions for the semiconductor industry and related markets, announces the cooperation with Swansea University's Centre for NanoHealth (CNH). This cooper...

From SUSS MicroTec AG 24 Nov 2011

Research and Markets Offers Textbook on Nanomedicine Field

Research and Markets now offers a new book titled ‘Understanding Nanomedicine: An Introductory Textbook.’

24 Nov 2011

The Healthcare Industry to Benefit from Nanotechnology

The healthcare market is poised to see some of the earliest benefits of nanotechnology. Over the next decade, it will be one of nanotech's highest growth sectors. Targeted drug delivery therapies for the treatment of...

23 Nov 2011

Selecta Biosciences Begins Phase 1 Human Clinical Trial of Nanoparticle Nicotine Vaccine

Selecta Biosciences has started the Phase 1 clinical study for the evaluation of pharmacodynamic profile, tolerability and safety of its nicotine nanoparticle vaccine candidate called SEL-068 for relapse prevention and smoking cessation.

23 Nov 2011

Alnylam Reports Preliminary Clinical Data of Lipid Nanoparticle Technology-Based RNAi Therapeutics

Tekmira Pharmaceuticals, a biopharmaceutical company specializing in novel RNA interference (RNAi) therapeutics, has announced that Alnylam Pharmaceuticals has reported preliminary results of a Phase I clinical study of an RNAi therapeutic targeting transthyretin (TTR) called ALN-TTR01 for TTR-mediated amyloidosis (ATTR) using the lipid nanoparticle technology (LNP) of Tekmira.

23 Nov 2011

Nanomedicine News

Quest PharmaTech’s Nanoformulation of Photosensitizer Demonstrates Superior Anti-tumor Effect

Bacteria Destroying Nanoparticle Developed by IBN and IBM Named as a Top 10 World Changing Idea

Drug Delivery Companies Partner to Develop Commercial Production Process for Silicon Nanoparticles

Lipid Nanoparticle Technology Developer Secures FDA Approval to Start TKM-Ebola Clinical Trial

Malvern's Light Scattering to Make Impact in Biopharmaceutical Development

SUSS Microtech Collaborate with Swansea University's Centre for NanoHealth

Research and Markets Offers Textbook on Nanomedicine Field

The Healthcare Industry to Benefit from Nanotechnology

Selecta Biosciences Begins Phase 1 Human Clinical Trial of Nanoparticle Nicotine Vaccine

Alnylam Reports Preliminary Clinical Data of Lipid Nanoparticle Technology-Based RNAi Therapeutics

Scientists Create the Largest Atomically Thin Gold Films to Make Electronics Weightless and Invisible

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Sustainable Future for Carbon Nanotubes

Enhancing Material Properties through Nanotube Encapsulation

Novel Nanobody Inhibitors Against Ebola Virus: Nanosota-EB1 and Nanosota-EB2

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials